Disruption of Nitric Oxide Synthase 3 Protects Against the Cardiac Injury, Dysfunction, and Mortality Induced by Doxorubicin
Tomas G. Neilan(Albert Einstein College of Medicine), Kenneth D. Bloch(Harvard University), Amanda Graveline(Harvard University), Elissa Furutani(Vlaams Instituut voor Biotechnologie), Marielle Scherrer‐Crosbie(University of Pennsylvania), Sarah L. Blake(Vlaams Instituut voor Biotechnologie), Michael J. Raher(Vlaams Instituut voor Biotechnologie), Stefan Janssens(Maastricht University), Fumito Ichinose(Harvard University), Davinder S. Jassal(St. Boniface Hospital), Emmanuel S. Buys(Harvard University), Teresa M. Pérez-Sanz(Vlaams Instituut voor Biotechnologie), Michael H. Picard(Harvard University)
Cited by 167
Related Papers
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
|Journal of the American Society of Echocardiography|2015|18k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
|European Heart Journal - Cardiovascular Imaging|2015|8.3k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Recommendations for chamber quantification☆
|European Journal of Echocardiography|2006|3.6k